The COVID-19 pandemic is an unprecedented global situation. As assisted reproductive technology (ART) specialists, we should be cautious, carefully monitoring the situation while contributing by sharing novel evidence to counsel our patients, both pregnant women and would-be mothers. Time to egg collection and drop-out rates are critical parameters for scheduling treatments once the curve of infections has peaked and plateaued in each country. In order to reduce the values for these two parameters, infertile patients now require even more support from their IVF team: urgent oocyte collection for oncology patients must be guaranteed, and oocyte retrievals for women of advanced maternal age and/or reduced ovarian reserve cannot be postponed indefinitely. This document represents the position of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) in outlining ART priorities during and after this emergency.

中文翻译：

---

COVID-19和ART：意大利生育，不育和生殖医学学会的观点。

COVID-19大流行是前所未有的全球形势。作为辅助生殖技术（ART）专家，我们应该谨慎，谨慎地监测情况，同时通过分享新颖的证据为我们的患者（包括孕妇和准妈妈）提供咨询意见。一旦感染曲线在每个国家达到峰值并达到平稳，收集鸡蛋的时间和脱落率是安排治疗计划的关键参数。为了降低这两个参数的值，不育患者现在需要其IVF团队更多的支持：必须保证为肿瘤患者紧急收集卵母细胞，并且不能为高产妇和/或卵巢储备减少的女性取卵。无限期推迟。